Health Worlds

Foreign media reported on Monday that the large U.S. retail chain operators, such as Sachs (SKS), Abercrombie & Fitch and Target (Target) so that they will be later this week in stores open at least a year, sales in July report. Analysts expect consumers to cut consumption by the anxiety of the large retailers to start spending and the impact of discounts, U.S. retailers reported July retail sales are expected to achieve only modest growth.
According to data provided by Thomson Reuters, analysts on average expect their investigation, in July same-store retail sales 3.2%, last year the figure was down 5.1%. Department stores and discount retailers reported the biggest increase is expected.
July retail sales will also be the first 11 months of continuous improvement, analysts warned that last year's figures are easy to break, but new threats will appear.
According to Thomson Reuters / University of Michigan consumer confidence survey, the U.S. July consumer confidence index hit a 9 months to the lowest level, employment and income prospects dim that consumers may be in the next few months, reduction in personal consumption expenditures.
Other factors may affect the performance of retailers, discount promotions from merchants, since the discount from June to promote the sales promotion has become the primary means of business.
Cowen & Co. analyst Laura Champine (Laura Champine) said: "The consumer confidence survey results are terrible, and we see the


promotion in the market is quite fierce."
As of Friday's close, the S & P retail index set April 26 as compared to 52-week high has dropped by 19%, underperformed the broader Standard & Poor's 500 index, which prompted investors to worry that consumer spending could start to accelerate worse.
Since April 26 from the stock fell sharply retailers include: JC Penney Company (JCP), whose shares fell 23.9%; Abercrombie & Fitch (ANF), fell 25.4%; TJX Companies (TJX), fell 13.3% ; and Target (TGT), fell 11.6%.
Analysts expected July sales gains may come from the largest department store operators, such as Macy's (M), Kohl Department Store (Kohl's, KSS) and Penney, in addition to the store as the discount retailer Ross (ROST) and TJX Companies.
Analysts expect discount stores in July same-store sales to rise 3.9%, department stores are expected to report an increase of 5.2%.
Tencent Finance
Anxiety Disorders Association of America
Anxiety Disorders Association of America (ADAA) is the only United States. Non-profit organization solely committed to increasing awareness and improved diagnosis, treatment and treatment of anxiety disorders.
One in six adults suffer from anxiety disorders [1] and anxiety disorders are the most common mental illness in adults and children. ADAA provides information on anxiety disorders, local treatment providers, self-help groups, self-test, clinical trials and more free educational information and res. ADAA promote the message of anxiety disorder is real, serious and treatable.Established in 1980 as the fear of the United States by a different group of social workers and patients of clinical, ADAA changed its name 10 years after the study to better identify the reflection of the more sophisticated the distinct anxiety disorder. Organizations to continue to clinicians, researchers and consumer services from its Silver Spring, Md. Headquarters by funding cutting-edge scientific research through grants and awards and to remind the Americans by promoting awareness of anxiety disorder is real and treatable.
ADAA is a member, Scientific Advisory Board and Clinical Advisory Board to guide and support through donations. Association also held an annual meeting and published through its Web site is completely available and information about self-help books and pamphlets.
References ^ National Institute of Mental HealthThe original work was translated from English to Chinese Traditional. To the original article please here.
Creative Commons Licence

Anxiety Disorders Association of America reports that the annual meeting: an experimental drug escitalopram (brand name Lexapro) to treat three different types of anxiety disorders: generalized anxiety disorder (GAD), phobia and social anxiety disorder.
One experiment done by Duke University researchers, which shows a significant reduction in 240 escitalopram GAD patients (18-80 years) symptoms. "Participate in the trial of the GAD patients treated with drugs than with placebo received better," lead Davidson (Jonathan Davidson) said. He is the University Medical Center Anxiety and Traumatic Stress, director of the Department. Patients after 4 weeks, to a variety of methods (mainly the Hamilton Anxiety Scale - HAMA) found that drugs reduce the symptoms of GAD, such as anxiety, fear, fatigue and irritability and so on. Qualified to participate in the trial of patients with HAMA score should not be less than 18 points, which indicates moderate GAD. Results of patients treated groups HAMA scores were reduced by 10 points in the placebo group, the average reduction of 7 points. But the drugs are nausea, vomiting, headaches and sexual dysfunction and other side effects. Second, the three study subjects were 247 patients and 358 social phobia anxiety disorder cheek line and Zhong chat reference file to persuade recruits RB satisfied sigh trouble basis?
Expert Hathorn (Youssef Hassoun) - University of Connecticut Health Center psychiatry chief resident that, escitalopram promising for the treatment of anxiety disorders. He said, "people are most interested in the drug is that these experiments show that it is better than placebo in treating anxiety disorders." Difference between the effectiveness of an important new drug indication. Escitalopram is a selective 5-HT reuptake inhibitors (SSRIs) for a class of drugs that are safe first-line treatment of anxiety measures, the patient can tolerate without harm. Forest Laboratories Company in March 2001 listing applications for FDA approved drugs, FDA in January this year signed a consent form. Company expects to drugs listed in this year.
United States each year, about 3-4% of GAD patients, characterized by more than 6 months and no reason to chronic excessive anxiety and tension. Phobia in the U.S. population between the ages of 18-54 has 240 million patients, the patient has a short onset of extreme fear, accompanied by a variety of physical symptoms, such as rapid heartbeat, difficulty breathing, dizziness or nausea, the condition can not the recurrence of any external threat. Social anxiety disorder, in the age group 18-54 years old among the 530 million patients, they are very afraid of others to pay attention and watch their behavior to their own fear of embarrassment and shame.


Friends Links:Automation Control Blog
Automation Products Order Numbers